Clinical Trials

clinical-trial-alert-image
Blog Post

Clinical Trial Alert: Phase 2 Study of Oral Ifetroban in Individuals with DMD

By Sujatha Gurunathan | August 10, 2022
Blog Post

Simply Stated: What is Myasthenia Gravis (MG)?

By Sujatha Gurunathan | June 27, 2022
Blog Post

Eledon Announces Positive Topline Results from a Phase 2a Study of Tegoprubart to Treat ALS

By Sujatha Gurunathan | June 1, 2022
Man in an electric wheelchair on a footpath in a suburban setting.
Featured Article

Understanding Amyotrophic Lateral Sclerosis

By MDA Staff | May 13, 2022
Scientific conference speakers
Featured Article

A Successful In-Person Conference

By MDA Staff | May 13, 2022
Blog Post

Simply Stated: Inclusion Body Myositis, Revisited

By Sujatha Gurunathan | April 27, 2022
Blog Post

Promoting Diversity in Rare Disease Research

By Larry Luxner | April 8, 2022
Blog Post

Simply Stated: What is Myotonic Dystrophy?

By Sujatha Gurunathan | March 24, 2022
Clinical & Scientific Conference
Blog Post

2022 Clinical & Scientific Conference: March 16 Highlights

By Sujatha Gurunathan | March 16, 2022
dystrophin
Blog Post

Simply Stated: What is Duchenne Muscular Dystrophy?

By Sujatha Gurunathan | February 16, 2022